• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人工肝支持,1985年]

[Artificial liver support 1985].

作者信息

Brunner G, Lösgen H

出版信息

Leber Magen Darm. 1985 Sep;15(5):186-91.

PMID:3903406
Abstract

Many techniques have been developed to support liver function in patients with hepatic failure. Only two of these methods are suited to be used in adequately equipped hospitals under appropriate safety conditions. Exchange of toxin-rich patient plasma against fresh frozen plasma will decrease plasma toxin levels and substitute coagulation factors and proteins. This procedure however should be used in intervals of at least 3-4 days because more frequent application will lead to lung or cerebral complications. Dialysis and hemofiltration will remove water soluble toxins from patient blood as well as excess amino acids which are considered to be precursors of toxic lipophilic metabolites. Addition of certain amino acids to dialysis fluid in physiological concentrations will help to avoid loss of essential amino acids (with approx. normal plasma concentration). In a very few special centers treatment by liver perfusion of human or pavian livers, or by liver transplantation can be performed.

摘要

已经开发出许多技术来支持肝功能衰竭患者的肝功能。在适当的安全条件下,只有其中两种方法适合在设备齐全的医院中使用。用新鲜冰冻血浆置换富含毒素的患者血浆将降低血浆毒素水平,并替代凝血因子和蛋白质。然而,此程序应至少间隔3 - 4天使用,因为更频繁的应用会导致肺部或脑部并发症。透析和血液滤过将从患者血液中去除水溶性毒素以及过量的氨基酸,这些氨基酸被认为是有毒亲脂性代谢物的前体。在透析液中添加生理浓度的某些氨基酸将有助于避免必需氨基酸的流失(血浆浓度约正常)。在极少数特殊中心,可以进行人或禽类肝脏的肝灌注治疗或肝移植。

相似文献

1
[Artificial liver support 1985].[人工肝支持,1985年]
Leber Magen Darm. 1985 Sep;15(5):186-91.
2
Liver support technology--an update.肝脏支持技术——最新进展
Xenotransplantation. 2006 Sep;13(5):380-9. doi: 10.1111/j.1399-3089.2006.00323.x.
3
[Artificial liver].[人工肝]
Nihon Geka Gakkai Zasshi. 1985 Sep;86(9):1027-30.
4
[Comments on the current treatment of fulminant liver failure].[关于暴发性肝衰竭当前治疗方法的评论]
Rev Clin Esp. 1989 Feb;184(3):143-6.
5
Artificial liver support systems.人工肝支持系统
J Assoc Physicians India. 2004 Sep;52:719-22.
6
Extracorporeal methods of liver failure treatment.肝衰竭治疗的体外方法。
Biomater Artif Cells Artif Organs. 1987;15(4):667-75.
7
Plasma exchange-based plasma recycling dialysis system as a potential platform for artificial liver support.基于血浆置换的血浆循环透析系统作为人工肝支持的潜在平台。
Artif Organs. 2006 Aug;30(8):629-33. doi: 10.1111/j.1525-1594.2006.00273.x.
8
[Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].[白蛋白透析治疗晚期肝功能不全患者的疗效:西班牙MARS系统的初步经验]
Nefrologia. 2001 Jul-Aug;21(4):376-85.
9
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
10
Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency.
Transplant Proc. 2005 Oct;37(8):3315-7. doi: 10.1016/j.transproceed.2005.09.007.